Safety and effectiveness of propofol‐based monitored anesthesia care without intubation during endoscopic submucosal dissection for early gastric and esophageal cancers
- 10 March 2015
- journal article
- research article
- Published by Wiley in Digestive Endoscopy
- Vol. 27 (6) , 665-673
Abstract
Background and Aim: Endoscopic submucosal dissection (ESD) becomes more difficult with an increased risk of complications if patient sedation is insufficient. We assessed the safety and effectiveness of propofol‐based monitored anesthesia care (MAC) without intubation during ESD for early esophageal cancer (EEC) or early gastric cancer (EGC) in the endoscopy room.Methods: We investigated 1013 consecutive patients with 1126 lesions who underwent ESD for EGC/EEC with either MAC or regular sedation by endoscopists (control group) between July 2010 and March 2013. Patient characteristics, endoscopic findings, technical results, body movement, oxygen saturation ( SpO2 ), and drug dosages were then examined.Results: MAC was carried out in 137 EGC (16%) and 82 EEC patients (57%), whereas regular sedation was used in 731 EGC (84%) and 63 EEC patients (43%). MAC was conducted in 21% of all ESD procedures. In the MAC and control groups, body movement requiring a third person for control occurred in 30 (22%) and 533 (72%) cases during gastric ESD (P < 0.0001) and in 36 (44%) and 53 (84%) cases during esophageal ESD (P < 0.0001), respectively. The median minimum SpO2 was significantly lower in the MAC group than in the control group during both gastric and esophageal ESD (96% vs 98%, P < 0.0001; 96% vs 98%, P < 0.0004, respectively). MAC did not cause any adverse effects requiring prolongation of hospitalization.Conclusions: Propofol‐based MAC without intubation provided a safer treatment environment by significantly reduced body movement and was very effective for difficult cases requiring longer procedure times or more powerful sedation.Keywords
This publication has 20 references indexed in Scilit:
- CURRENT STATUS OF COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION IN JAPAN AND OTHER ASIAN COUNTRIES: PROGRESSING TOWARDS TECHNICAL STANDARDIZATIONDigestive Endoscopy, 2012
- Clinical impact of a strategy involving endoscopic submucosal dissection for early gastric cancer: determining the optimal pathwayGastric Cancer, 2011
- Modeling the Effect of Propofol and Remifentanil Combinations for Sedation-Analgesia in Endoscopic Procedures Using an Adaptive Neuro Fuzzy Inference System (ANFIS)Anesthesia & Analgesia, 2011
- Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteriaBritish Journal of Surgery, 2010
- Safe and effective sedation in endoscopic submucosal dissection for early gastric cancer: a randomized comparison between propofol continuous infusion and intermittent midazolam injectionJournal of Gastroenterology, 2010
- ENDOSCOPIC SUBMUCOSAL DISSECTION FOR ESOPHAGEAL SQUAMOUS CELL NEOPLASMSDigestive Endoscopy, 2009
- Sedation and anesthesia in GI endoscopyGastrointestinal Endoscopy, 2008
- Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2007 edition: part I Edited by the Japan Esophageal SocietyEsophagus, 2008
- Endoscopic resection of early gastric cancerGastric Cancer, 2007
- ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC CANCER: TECHNICAL FEASIBILITY, OPERATION TIME AND COMPLICATIONS FROM A LARGE CONSECUTIVE SERIESDigestive Endoscopy, 2004